{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:45:33Z","timestamp":1771929933709,"version":"3.50.1"},"reference-count":169,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.brainres.2025.149505","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T16:27:04Z","timestamp":1739464024000},"page":"149505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Outlook of SNCA (\u03b1-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"1852","author":[{"given":"Jennifer Sally","family":"Samson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyanaraman","family":"Rajagopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkatachalam Deepa","family":"Parvathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2025.149505_b0005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2025.149505_b0010","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of \u03b1-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0015","doi-asserted-by":"crossref","unstructured":"Aryal B and Lee Y (2019) Disease model organism for Parkinson disease: Drosophila melanogaster. BMB Rep. 52:250. doi: 10.5483%2FBMBRep.2019.52.4.204.","DOI":"10.5483\/BMBRep.2019.52.4.204"},{"key":"10.1016\/j.brainres.2025.149505_b0020","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/nm1102-1185","article-title":"Pharmacological prevention of Parkinson disease in Drosophila","volume":"8","author":"Auluck","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2025.149505_b0025","article-title":"Haploinsufficiency of cathepsin D leads to lysosomal dysfunction and promotes cell-to-cell transmission of \u03b1-synuclein aggregates","volume":"6:e1901-","author":"Bae","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0030","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.febslet.2010.03.012","article-title":"\u03b1-Synuclein induced membrane depolarization and loss of phosphorylation capacity of isolated rat brain mitochondria: Implications in PD","volume":"584","author":"Banerjee","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2025.149505_b0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis","volume":"1792","author":"Banerjee","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0040","doi-asserted-by":"crossref","unstructured":"Bender A, Desplats P, Spencer B, Rockenstein E, Adame A, Elstner M, Laub C, Mueller S, Koob AO, Mante M, Pham E (2013) TOM40 mediates mitochondrial dysfunction induced by \u03b1-synuclein accumulation in PD. PloS one 8: e62277. doi: 10.1371\/journal.pone.0062277.","DOI":"10.1371\/journal.pone.0062277"},{"key":"10.1016\/j.brainres.2025.149505_b0045","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.3389\/fnins.2019.01399","article-title":"Alpha-Synuclein Physiology and Pathology: A Perspective on Cellular Structures and Organelles","volume":"13","author":"Bernal-Conde","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0055","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.expneurol.2004.08.021","article-title":"Ubiquitin\u2013proteasome system and Parkinson's diseases","volume":"191","author":"Betarbet","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2025.149505_b0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12013-007-0014-9","article-title":"Mechanistic aspects of PD: \u03b1-synuclein and the biomembrane","volume":"47","author":"Beyer","year":"2007","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.brainres.2025.149505_b0065","doi-asserted-by":"crossref","unstructured":"Blosser JA, Podolsky E, Lee D (2020) L-DOPA-induced dyskinesia in a genetic drosophila model of PD. Exp Neurobiol 29: 273. doi: 10.5607%2Fen20028.","DOI":"10.5607\/en20028"},{"key":"10.1016\/j.brainres.2025.149505_b0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.nbd.2007.11.013","article-title":"Superoxide dismutase overexpression protects DA neurons in a Drosophila model of Parkinson's disease","volume":"30","author":"Botella","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0075","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson's disease","volume":"2","author":"Bov\u00e9","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.brainres.2025.149505_b0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1242\/dev.118.2.401","article-title":"Targeted gene expression as a means of altering cell fates and generating dominant phenotypes","volume":"118","author":"Brand","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.brainres.2025.149505_b0085","article-title":"Presynaptic accumulation of \u03b1-synuclein causes synaptopathy and progressive neurodegeneration in Drosophila","volume":"3(2):fcab049","author":"Bridi","year":"2021","journal-title":"Brain Commun"},{"key":"10.1016\/j.brainres.2025.149505_b0090","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/prot.23152","article-title":"Inhibition of \u03b1\u2010synuclein aggregation by small heat shock proteins. Proteins: Structure","volume":"79","author":"Bruinsma","year":"2011","journal-title":"Function, and Bioinformatics"},{"key":"10.1016\/j.brainres.2025.149505_b0095","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/biomedicines8120591","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: focus on mitochondrial DNA","volume":"8","author":"Buneeva","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.brainres.2025.149505_b0100","doi-asserted-by":"crossref","unstructured":"Butler EK, Voigt A, Lutz AK, Toegel JP, Gerhardt E, Karsten P, Falkenburger B, Reinartz A, Winklhofer KF, Schulz JB (2012) The mitochondrial chaperone protein TRAP1 mitigates \u03b1-Synuclein toxicity. PLoS Genet 8: e1002488.doi: 10.1371\/journal.pgen.1002488.","DOI":"10.1371\/journal.pgen.1002488"},{"key":"10.1016\/j.brainres.2025.149505_b0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00018-022-04166-9","article-title":"Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies","volume":"79","author":"Cascella","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.brainres.2025.149505_b0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijbiomac.2013.05.032","article-title":"Applying chaperones to protein-misfolding disorders: molecular chaperones against \u03b1-synuclein in Parkinson's disease","volume":"60","author":"Chaari","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.brainres.2025.149505_b0115","doi-asserted-by":"crossref","unstructured":"Chen AY, Xia S, Wilburn P, Tully T (2014) Olfactory deficits in an alpha-synuclein fly model of PD. PloS one 9: e97758. doi: 10.1371\/journal.pone.0097758.","DOI":"10.1371\/journal.pone.0097758"},{"key":"10.1016\/j.brainres.2025.149505_b0120","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of \u03b1-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"Chen","year":"2009","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.brainres.2025.149505_b0125","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/gbb.12172","article-title":"Walking deficits and centrophobism in an \u03b1\u2010synuclein fly model of PD","volume":"13","author":"Chen","year":"2014","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.brainres.2025.149505_b0130","first-page":"1362","article-title":"Redox imbalance in Parkinson's disease","volume":"1780","author":"Chinta","year":"2008","journal-title":"BBA"},{"key":"10.1016\/j.brainres.2025.149505_b0135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.neulet.2010.09.061","article-title":"Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo","volume":"486","author":"Chinta","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2025.149505_b0140","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.3390\/ijms25126711","article-title":"Downregulation of Protease Cathepsin D and Upregulation of Pathologic \u03b1-Synuclein Mediate Paucity of DNAJC6-Induced Degeneration of DA Neurons","volume":"25","author":"Chiu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149505_b0145","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2025.149505_b0150","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the \u03b1-synuclein protofibril by a dopamine-\u03b1-synuclein adduct","volume":"294","author":"Conway","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149505_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol. Brain"},{"key":"10.1016\/j.brainres.2025.149505_b0160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","article-title":"Genetic animal models of Parkinson's disease","volume":"66","author":"Dawson","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2025.149505_b0165","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"De Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2025.149505_b0170","doi-asserted-by":"crossref","unstructured":"Demir E, Demir FT, Marcos R (2022) Drosophila as a suitable in vivo model in the safety assessment of nanomaterials. In: Nanotoxicology in Safety Assessment of Nanomaterials 1st edn. Springer Cham, pp 275-301. doi: 10.1007\/978-3-030-88071-2_12.","DOI":"10.1007\/978-3-030-88071-2_12"},{"key":"10.1016\/j.brainres.2025.149505_b0175","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of \u03b1-synuclein impair complex I in human DAergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0180","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"\u03b1-Synuclein binds to TOM20 and inhibits mitochondrial protein import in PD","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.brainres.2025.149505_b0185","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/WNR.0000000000001495","article-title":"Role of alpha-synuclein phosphorylation at Serine 129 in methamphetamine-induced neurotoxicity in vitro and in vivo","volume":"31","author":"Ding","year":"2020","journal-title":"Neuroreport"},{"key":"10.1016\/j.brainres.2025.149505_b0195","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1091\/mbc.e10-03-0200","article-title":"Drosophila histone deacetylase 6 protects DA neurons against \u03b1-synuclein toxicity by promoting inclusion formation","volume":"21","author":"Du","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.brainres.2025.149505_b0200","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","article-title":"Cell-produced \u03b1-synuclein oligomers are targeted to, and impair, the 26S proteasome","volume":"31","author":"Emmanouilidou","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2025.149505_b0205","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1093\/hmg\/ddu165","article-title":"The novel PD linked mutation G51D attenuates in vitro aggregation and membrane binding of \u03b1-synuclein, and enhances its secretion and nuclear localization in cells","volume":"23","author":"Fares","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2025.149505_b0210","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuro.2019.03.005","article-title":"Neuroprotective role of kolaviron in striatal redo-inflammation associated with rotenone model of PD","volume":"73","author":"Farombi","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.brainres.2025.149505_b0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/genes8120377","article-title":"Mitochondria and \u03b1-synuclein: friends or foes in the pathogenesis of Parkinson\u2019s disease?","volume":"8","author":"Faustini","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.brainres.2025.149505_b0220","first-page":"394","volume":"404","author":"Feany","year":"2000","journal-title":"A Drosophila Model of PD. Nature"},{"key":"10.1016\/j.brainres.2025.149505_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1116000","article-title":"Drosophila melanogaster as a versatile model organism to study genetic epilepsies: An overview","volume":"16","author":"Fischer","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0230","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","article-title":"Inhibition of HDAC6 activity protects DA neurons from alpha-synuclein toxicity","volume":"10","author":"Francelle","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2025.149505_b0235","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/hmg\/ddw428","article-title":"A Drosophila model system to assess the function of human monogenic podocyte mutations that cause nephrotic syndrome","volume":"26","author":"Fu","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.brainres.2025.149505_b0240","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"\u03b1-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.brainres.2025.149505_b0245","article-title":"\u03b1-Synuclein and Mitochondria: Probing the Dynamics of Disordered Membrane-protein Regions Using Solid-State Nuclear Magnetic Resonance","volume":"2024","author":"Gallo","year":"2024","journal-title":"JACS Au"},{"key":"10.1016\/j.brainres.2025.149505_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43042-021-00208-2","article-title":"Deconstructing the molecular genetics behind the PINKI\/Parkin axis in PD using Drosophila melanogaster as a model organism","volume":"22","author":"Ganesan","year":"2021","journal-title":"Egypt J Med Hum Genet"},{"key":"10.1016\/j.brainres.2025.149505_b0255","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41419-019-2091-2","article-title":"Mitochondrial damage by \u03b1-synuclein causes cell death in human DAergic neurons","volume":"10","author":"Ganjam","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0260","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1039\/c8mt00232k","article-title":"Interaction of Cu (i) with the Met-X 3-Met motif of alpha-synuclein: binding ligands, affinity and structural features","volume":"10","author":"Gentile","year":"2018","journal-title":"Metallomics"},{"key":"10.1016\/j.brainres.2025.149505_b0265","doi-asserted-by":"crossref","unstructured":"Ghanem SS, Majbour NK, Vaikath NN, Ardah MT, Erskine D, Jensen NM, Fayyad M, Sudhakaran IP, Vasili E, Melachroinou K, Abdi IY (2022) \u03b1-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity. Proc Natl Acad Sci 119: e2109617119. doi: 10.1073\/pnas.2109617119.","DOI":"10.1073\/pnas.2109617119"},{"key":"10.1016\/j.brainres.2025.149505_b0270","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1046\/j.1471-4159.2000.0752221.x","article-title":"Rat \u03b1\u2010synuclein interacts with Tat binding protein 1, a component of the 26S proteasomal complex","volume":"75","author":"Ghee","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149505_b0275","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0022-3565(25)22503-4","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration","volume":"270","author":"Giovanni","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2025.149505_b0280","doi-asserted-by":"crossref","unstructured":"Girard V, Jollivet F, Knittelfelder O, Arsac JN, Chatelain G, Van den Brink DM, Baron T, Shevchenko A, Davoust-Nataf N, Mollereau B (2020) Alpha-synuclein enhances lipid droplet accumulation in neurons in a Drosophila model of Parkinson\u2019s disease. bioRxiv 2020-09. doi: 10.1101\/2020.09.16.299354.","DOI":"10.1101\/2020.09.16.299354"},{"key":"10.1016\/j.brainres.2025.149505_b0285","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/nar\/26.4.865","article-title":"Genome structure and gene content in protist mitochondrial DNAs","volume":"26","author":"Gray","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2025.149505_b0290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/path.3028","article-title":"Mitochondrial DNA and disease","volume":"226","author":"Greaves","year":"2012","journal-title":"J. Pathol."},{"key":"10.1016\/j.brainres.2025.149505_b0295","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.1074\/jbc.M411638200","article-title":"The E46K mutation in \u03b1-synuclein increases amyloid fibril formation","volume":"280","author":"Greenbaum","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0300","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1126\/science.1068408","article-title":"Molecular chaperones in the cytosol: from nascent chain to folded protein","volume":"295","author":"Hartl","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149505_b0305","doi-asserted-by":"crossref","first-page":"49071","DOI":"10.1074\/jbc.M208046200","article-title":"Phosphorylated \u03b1-synuclein is ubiquitinated in \u03b1-synucleinopathy lesions","volume":"277","author":"Hasegawa","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0310","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.WNL.0000142089.38301.8E","article-title":"PINK1 (PARK6) associated Parkinson disease in Ireland","volume":"63","author":"Healy","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2025.149505_b0315","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease\u2013a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.brainres.2025.149505_b0320","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.brainres.2025.149505_b0325","first-page":"504","article-title":"Drosophila melanogaster in the study of human neurodegeneration. CNS Neurol Disord Drug Targets (Formerly Current Drug Targets-CNS & N","volume":"9","author":"Hirth","year":"2010","journal-title":"Neurological Disorders)"},{"key":"10.1016\/j.brainres.2025.149505_b0330","doi-asserted-by":"crossref","first-page":"e00007","DOI":"10.1128\/MCB.00007-21","article-title":"Reduce, retain, recycle: mechanisms for promoting histone protein degradation versus stability and retention","volume":"41","author":"Hogan","year":"2021","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.brainres.2025.149505_b0335","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0002-9440(10)64553-1","article-title":"\u03b1-Synuclein promotes mitochondrial deficit and oxidative stress","volume":"157","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2025.149505_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105527","article-title":"Molecular chaperones and Parkinson's disease","volume":"160","author":"Hu","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0345","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s42003-019-0674-1","article-title":"Light-driven activation of mitochondrial proton-motive force improves motor behaviors in a Drosophila model of PD","volume":"2","author":"Imai","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.brainres.2025.149505_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145811","article-title":"Saffron ameliorated motor symptoms, short life span and retinal degeneration in PD fly models","volume":"799","author":"Inoue","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.brainres.2025.149505_b0355","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI200317638","article-title":"Oxidative stress and nitration in neurodegeneration: cause, effect, or association?","volume":"111","author":"Ischiropoulos","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2025.149505_b0360","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2025.149505_b0365","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2015.02.048","article-title":"Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of PD","volume":"293","author":"Jahromi","year":"2015","journal-title":"Neurosci"},{"key":"10.1016\/j.brainres.2025.149505_b0370","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson\u2019s disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.brainres.2025.149505_b0375","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1515\/intox-2016-0012","article-title":"Organochlorine pesticides, their toxic effects on living organisms and their fate in the environment","volume":"9","author":"Jayaraj","year":"2016","journal-title":"Interdiscip. Toxicol."},{"key":"10.1016\/j.brainres.2025.149505_b0380","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/jnr.21650","article-title":"High doses of nicotinamide prevent oxidative mitochondrial dysfunction in a cellular model and improve motor deficit in a Drosophila model of Parkinson's disease","volume":"86","author":"Jia","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2025.149505_b0385","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1242\/dmm.014563","article-title":"Barcoding heat shock proteins to human diseases: looking beyond the heat shock response","volume":"7","author":"Kakkar","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.brainres.2025.149505_b0390","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of mitochondrial fusion by \u03b1\u2010synuclein is rescued by PINK1, Parkin and DJ\u20101","volume":"29","author":"Kamp","year":"2010","journal-title":"EMBO J."},{"key":"10.1016\/j.brainres.2025.149505_b0395","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3233\/JPD-130250","article-title":"The role of innate and adaptive immunity in Parkinson's disease","volume":"3","author":"Kannarkat","year":"2013","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0400","doi-asserted-by":"crossref","unstructured":"Karthik L, Kumar G, Keswani T, Bhattacharyya A, Chandar SS, Bhaskara Rao KV (2014) Protease inhibitors from marine actinobacteria as a potential source for antimalarial compound. PloS one 9: e90972. doi: 10.1371\/journal.pone.0090972.","DOI":"10.1371\/journal.pone.0090972"},{"key":"10.1016\/j.brainres.2025.149505_b0405","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ame2.12322","article-title":"Humanization for neurological disease modeling: A roadmap to increase the potential of Drosophila model systems","volume":"6","author":"Katanaev","year":"2023","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.brainres.2025.149505_b0410","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/ajmg.b.30758","article-title":"Genetic association between \u03b1\u2010synuclein and idiopathic PD","volume":"147","author":"Kay","year":"2008","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.brainres.2025.149505_b0415","doi-asserted-by":"crossref","first-page":"21856","DOI":"10.1074\/jbc.M114.553297","article-title":"The H50Q mutation enhances \u03b1-synuclein aggregation, secretion, and toxicity","volume":"289","author":"Khalaf","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0420","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008888","article-title":"Genetics of Parkinson\u2019s disease","volume":"2","author":"Klein","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.brainres.2025.149505_b0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/nar\/24.1.177","article-title":"MITOMAP: a human mitochondrial genome database","volume":"24","author":"Kogelnik","year":"1996","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.brainres.2025.149505_b0430","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.parkreldis.2015.09.007","article-title":"Autosomal dominant Parkinson's disease caused by SNCA duplications","volume":"22","author":"Konno","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.brainres.2025.149505_b0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1750-3639.2011.00545.x","article-title":"Autophagy in dementias","volume":"22","author":"Kragh","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.brainres.2025.149505_b0440","doi-asserted-by":"crossref","unstructured":"Kruger R, Kuhn W, Muller T, Woitalla D, Graeber M, Kosel S, Przuntek H. Epplen 1T, Schols L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106-108. doi: 10.1038\/ng0298-106.","DOI":"10.1038\/ng0298-106"},{"key":"10.1016\/j.brainres.2025.149505_b0445","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41419-021-04046-3","article-title":"Differential mitochondrial roles for \u03b1-synuclein in DRP1-dependent fission and PINK1\/Parkin-mediated oxidation","volume":"12","author":"Krzystek","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0450","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1266\/ggs.17-00024","article-title":"piggyBac-and phiC31 integrase-mediated transgenesis in Drosophila prolongata","volume":"92","author":"Kudo","year":"2017","journal-title":"Genes Genet. Syst."},{"key":"10.1016\/j.brainres.2025.149505_b0455","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrn3406","article-title":"The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target","volume":"14","author":"Lashuel","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0460","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/genetics\/158.4.1545","article-title":"A genetic screen for suppressors and enhancers of the Drosophila PAN GU cell cycle kinase identifies cyclin B as a target","volume":"158","author":"Lee","year":"2001","journal-title":"Genetics"},{"key":"10.1016\/j.brainres.2025.149505_b0465","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of \u03b1-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0470","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1471-4159.2009.06124.x","article-title":"The role of ubiquitin linkages on \u03b1\u2010synuclein induced\u2010toxicity in a Drosophila model of Parkinson\u2019s disease","volume":"110","author":"Lee","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149505_b0475","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.23894","article-title":"G51D \u03b1\u2010synuclein mutation causes a novel Parkinsonian\u2013pyramidal syndrome","volume":"73","author":"Lesage","year":"2013","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.brainres.2025.149505_b0480","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/cells11050851","article-title":"Ubiquitination-proteasome system (UPS) and autophagy two main protein degradation machineries in response to cell stress","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.brainres.2025.149505_b0485","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1073\/pnas.0401081101","article-title":"Ubiquitylation of synphilin-1 and \u03b1-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease","volume":"101","author":"Liani","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2025.149505_b0490","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson's disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.brainres.2025.149505_b0495","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson's disease: a case\u2010control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.brainres.2025.149505_b0500","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neulet.2009.02.056","article-title":"\u03b1-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity","volume":"454","author":"Liu","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2025.149505_b0505","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/rej.2009.0877","article-title":"Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model","volume":"12","author":"Long","year":"2009","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.brainres.2025.149505_b0510","doi-asserted-by":"crossref","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","article-title":"Soluble, prefibrillar \u03b1-synuclein oligomers promote complex I-dependent, Ca2+-induced mitochondrial dysfunction","volume":"289","author":"Luth","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0515","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jama.296.6.661","article-title":"Collaborative analysis of \u03b1-synuclein gene promoter variability and Parkinson disease","volume":"296","author":"Maraganore","year":"2006","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.brainres.2025.149505_b0520","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1089\/dna.2020.5398","article-title":"Damage in mitochondrial DNA associated with Parkinson's Disease","volume":"39","author":"Mart\u00edn-Jim\u00e9nez","year":"2020","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.brainres.2025.149505_b0525","unstructured":"Mata I, Samii A, Factor S, Higgins D, Griffith A, Roberts J, Kim H, Agarwal P, Yearout D, Hutter C, Edwards K (2009) Variation in the Alpha-Synuclein Gene, Independent of REPI, Modifies Risk for PD. Neurology 72: A393-A394."},{"issue":"1","key":"10.1016\/j.brainres.2025.149505_b0530","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40478-020-0894-0","article-title":"Early-onset impairment of the ubiquitin-proteasome system in DA neurons caused by \u03b1-synuclein","volume":"8","author":"McKinnon","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"issue":"2020\u201303","key":"10.1016\/j.brainres.2025.149505_b0535","article-title":"Hsp27 reduces glycation-induced toxicity and aggregation of \u03b1-synuclein","volume":"4","author":"Miranda","year":"2020","journal-title":"bioRxiv."},{"key":"10.1016\/j.brainres.2025.149505_b0540","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0306-4522(96)00100-5","article-title":"Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death?","volume":"73","author":"Mouatt-Prigent","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2025.149505_b0545","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/ana.20438","article-title":"Multiple regions of \u03b1\u2010synuclein are associated with PD","volume":"57","author":"Mueller","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2025.149505_b0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2020.04.002","article-title":"Molecular mechanism of mitochondrial respiratory chain assembly and its relation to mitochondrial diseases","volume":"53","author":"Mukherjee","year":"2020","journal-title":"Mitochondrion"},{"key":"10.1016\/j.brainres.2025.149505_b0555","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1111\/j.1471-4159.2009.06293.x","article-title":"The ubiquitin ligase E6\u2010AP promotes degradation of \u03b1\u2010synuclein","volume":"110","author":"Mulherkar","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149505_b0560","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41531-023-00535-8","article-title":"Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson\u2019s disease","volume":"9","author":"M\u00fcller-Nedebock","year":"2023","journal-title":"Npj Parkinsons Dis"},{"key":"10.1016\/j.brainres.2025.149505_b0565","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1172\/JCI127330","article-title":"Oxidative stress in vagal neurons promotes parkinsonian pathology and intercellular \u03b1-synuclein transfer","volume":"129","author":"Musgrove","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2025.149505_b0570","doi-asserted-by":"crossref","unstructured":"Narwal S, Rai A, Iyer SM, Tare KN, Tare M (2022) Neuroprotective potential of an Ayurvedic compound\u201c Ras Sindoor\u201d on Drosophila melanogaster model of PD. bioRxiv 2022-11. doi: 10.1101\/2022.11.18.517027.","DOI":"10.1101\/2022.11.18.517027"},{"key":"10.1016\/j.brainres.2025.149505_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105803","article-title":"Mitochondrial electron transport chain defects modify Parkinson's disease phenotypes in a Drosophila model","volume":"171","author":"O'Hanlon","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0580","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.neuron.2017.11.036","article-title":"\u03b1-synuclein induces mitochondrial dysfunction through spectrin and the actin cytoskeleton","volume":"97","author":"Ordonez","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2025.149505_b0585","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.3390\/ijms222212467","article-title":"Protein misfolding and aggregation: the relatedness between Parkinson\u2019s disease and hepatic endoplasmic reticulum storage disorders Int","volume":"22","author":"Padilla-God\u00ednez","year":"2021","journal-title":"J. Mol. Sci"},{"key":"10.1016\/j.brainres.2025.149505_b0590","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1523\/JNEUROSCI.5922-09.2010","article-title":"Phosphorylation at S87 is enhanced in synucleinopathies, inhibits \u03b1-synuclein oligomerization, and influences synuclein-membrane interactions","volume":"30","author":"Paleologou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0595","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/1873-3468.14022","article-title":"Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer","volume":"595","author":"Palmer","year":"2021","journal-title":"FEBS Lett."},{"key":"10.1016\/j.brainres.2025.149505_b0600","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neulet.2006.09.003","article-title":"Mutations in DJ-1 are rare in familial Parkinson disease","volume":"408","author":"Pankratz N, Pauciulo MW, Elsaesser VE, Marek DK, Halter CA, Wojcieszek J, Rudolph A, Shults CW, Foroud T, Nichols WC, Parkinson Study Group\u2013PROGENI Investigators","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2025.149505_b0605","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-018-0829-3","article-title":"Mitochondrial dysfunction in PD: new mechanistic insights and therapeutic perspectives","volume":"18","author":"Park","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.brainres.2025.149505_b0610","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.neurobiolaging.2014.03.024","article-title":"Novel \u03b1-synuclein mutation A53E associated with atypical multiple system atrophy and PD-type pathology","volume":"35","author":"Pasanen","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2025.149505_b0615","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj20040198","article-title":"Getting into position: the catalytic mechanisms of protein ubiquitylation","volume":"379","author":"Passmore","year":"2004","journal-title":"Biochem. J"},{"key":"10.1016\/j.brainres.2025.149505_b0620","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of \u03b1-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0625","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the \u03b1-synuclein gene identified in families with PD","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.brainres.2025.149505_b0630","first-page":"157","article-title":"Tissue-Specific CRISPR-Cas9 Screening in Drosophila","volume":"vol 2540","author":"Port","year":"2022"},{"key":"10.1016\/j.brainres.2025.149505_b0635","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1242\/dmm.026294","article-title":"Mitochondrial dynamics in Parkinson's disease: a role for \u03b1-synuclein?","volume":"10","author":"Pozo Devoto","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.brainres.2025.149505_b0640","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12192-016-0676-6","article-title":"The human HSP70 family of chaperones: where do we stand?","volume":"21","author":"Radons","year":"2016","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.brainres.2025.149505_b0645","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine, by mitochondria","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0650","doi-asserted-by":"crossref","first-page":"e1820","DOI":"10.1038\/cddis.2015.166","article-title":"Aggregated \u03b1-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons","volume":"6","author":"Reeve","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0655","article-title":"\u03b1-synuclein E46K mutation and involvement of oxidative stress in a drosophila model of PD","volume":"2021","author":"Reiszadeh Jahromi","year":"2021","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.brainres.2025.149505_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105685","article-title":"Rotenone induces regionally distinct \u03b1-synuclein protein aggregation and activation of glia prior to loss of DAergic neurons in C57Bl\/6 mice","volume":"167","author":"Rocha","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0665","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in PD","volume":"109","author":"Rocha","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0670","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41580-019-0133-3","article-title":"The Hsp70 chaperone network","volume":"20","author":"Rosenzweig","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.brainres.2025.149505_b0675","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1074\/jbc.M704809200","article-title":"Monoubiquitylation of \u03b1-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in DA cells","volume":"283","author":"Rott","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0680","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/jnc.12806","article-title":"Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of \u03b1\u2010synuclein","volume":"131","author":"Rutherford","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2025.149505_b0685","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.brainres.2025.149505_b0690","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for PD","volume":"41","author":"Satake","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2025.149505_b0695","doi-asserted-by":"crossref","first-page":"16884","DOI":"10.1523\/JNEUROSCI.3967-11.2011","article-title":"Authentically phosphorylated \u03b1-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease","volume":"31","author":"Sato","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0700","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)61113-3","article-title":"Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies","volume":"160","author":"Schlossmacher","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.brainres.2025.149505_b0705","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.brainres.2025.149505_b0710","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of \u03b1-synuclein and generation of its carboxy-terminally truncated species","volume":"47","author":"Sevlever","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainres.2025.149505_b0715","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00401-018-1873-4","article-title":"Alpha-synuclein delays mitophagy and targeting Miro rescues neuron loss in Parkinson\u2019s models","volume":"136","author":"Shaltouki","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2025.149505_b0720","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of PD","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0725","doi-asserted-by":"crossref","first-page":"23727","DOI":"10.1074\/jbc.M503326200","article-title":"The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates \u03b1-synuclein degradation decisions between proteasomal and lysosomal pathways","volume":"280","author":"Shin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0730","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying PD","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.brainres.2025.149505_b0735","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","article-title":"Aggregated and monomeric \u03b1-synuclein bind to the S6\u2032 proteasomal protein and inhibit proteasomal function","volume":"278","author":"Snyder","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2025.149505_b0740","series-title":"Encyclopedia of Neuroscience","first-page":"1662","article-title":"GAL4\/UAS Expression System","author":"Sonnenfeld","year":"2009"},{"key":"10.1016\/j.brainres.2025.149505_b0745","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2025.149505_b0750","article-title":"Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson\u2019s disease?","volume":"1767","author":"Subrahmanian","year":"2021","journal-title":"A Critical Reappraisal. Brain Res"},{"key":"10.1016\/j.brainres.2025.149505_b0755","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.947191","article-title":"The relationship of alpha-synuclein to mitochondrial dynamics and quality control","volume":"15","author":"Thorne","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0760","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1089\/ars.2011.4200","article-title":"Mitochondrial dysfunction in genetic animal models of Parkinson's disease","volume":"16","author":"Trancikova","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.brainres.2025.149505_b0765","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1742-4658.2012.08489.x","article-title":"Role of \u03b1\u2010synuclein penetration into the membrane in the mechanisms of oligomer pore formation","volume":"279","author":"Tsigelny","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.brainres.2025.149505_b0770","doi-asserted-by":"crossref","unstructured":"Tunesi M, Raimondi I, Russo T, Colombo L, Micotti E, Brandi E, Cappelletti P, Cigada A, Negro A, Ambrosio L, Forloni G (2019) Hydrogel-based delivery of Tat-fused protein Hsp70 protects DA cells in vitro and in a mouse model of Parkinson\u2019s disease. \u201cNPG Asia Mater11:28. doi: 10.1038\/s41427-019-0128-8.","DOI":"10.1038\/s41427-019-0128-8"},{"key":"10.1016\/j.brainres.2025.149505_b0775","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2012.05.015","article-title":"The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for PD","volume":"51","author":"Van Laar","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.149505_b0780","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1242\/dev.005686","article-title":"Transgenesis upgrades for Drosophila melanogaster","volume":"134","author":"Venken","year":"2007","journal-title":"Development"},{"key":"10.1016\/j.brainres.2025.149505_b0785","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tig.2015.01.004","article-title":"Progress in unraveling the genetic etiology of Parkinson disease in a genomic era","volume":"31","author":"Verstraeten","year":"2015","journal-title":"Trends Genet."},{"key":"10.1016\/j.brainres.2025.149505_b0790","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/cells10030579","article-title":"The importance of Drosophila melanogaster research to uncover cellular pathways underlying Parkinson\u2019s disease","volume":"10","author":"Vos","year":"2021","journal-title":"Cells"},{"issue":"591475","key":"10.1016\/j.brainres.2025.149505_b0795","article-title":"Exogenous alpha-synuclein evoked parkin downregulation promotes mitochondrial dysfunction in neuronal cells. Implications for Parkinson\u2019s disease pathology","volume":"13","author":"Wilkaniec","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0800","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that \u03b1-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2025.149505_b0805","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3390\/antiox11122466","article-title":"Neuronal oxidative stress promotes \u03b1-synuclein aggregation in vivo","volume":"11","author":"Won","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.brainres.2025.149505_b0810","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/mds.27823","article-title":"Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?","volume":"34","author":"Wong","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.brainres.2025.149505_b0815","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-019-0159-7","article-title":"Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy","volume":"8","author":"Wu","year":"2019","journal-title":"Transl Neurodegener"},{"key":"10.1016\/j.brainres.2025.149505_b0820","article-title":"Alpha\u2010Synuclein in Parkinson\u2019s Disease: From Pathogenetic Dysfunction to Potential Clinical Application","volume":"2016","author":"Xu","year":"2016","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.brainres.2025.149505_b0825","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","article-title":"Inhibition of mitochondrial protein import by mutant huntingtin","volume":"17","author":"Yano","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2025.149505_b0830","doi-asserted-by":"crossref","first-page":"14753","DOI":"10.3390\/ijms232314753","article-title":"Pathogenesis of \u03b1-Synuclein in Parkinson\u2019s Disease: From a Neuron-Glia Crosstalk Perspective","volume":"23","author":"Yi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2025.149505_b0835","first-page":"323","article-title":"Role of post-translational modifications on the alpha-synuclein aggregation-related pathogenesis of Parkinson\u2019s disease","volume":"55","author":"Yoo","year":"2022","journal-title":"Bmbrep"},{"key":"10.1016\/j.brainres.2025.149505_b0840","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of \u03b1\u2010synuclein causes parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2025.149505_b0845","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1046\/j.1471-4159.2003.02273.x","article-title":"HSP27 but not HSP70 has a potent protective effect against \u03b1\u2010synuclein\u2010induced cell death in mammalian neuronal cells","volume":"88","author":"Zourlidou","year":"2004","journal-title":"J. Neurochem."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T01:51:59Z","timestamp":1740793919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":169,"alternative-id":["S0006899325000630"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149505","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outlook of SNCA (\u03b1-synuclein) transgenic fly models in delineating the sequel of mitochondrial dysfunction in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.149505","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"149505"}}